Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Preusser

Showing results (11-20 of 525) with videos related to

Pageof 53
Sort By:
The Lancet. Oncology|November 6, 2012
Primary systemic treatment of breast-cancer brain metastasesRupert Bartsch, Matthias Preusser
Current Treatment Options in Neurology|May 16, 2015
Antiangiogenic treatment of meningiomasMatthias Preusser, Christine Marosi
Nature Reviews. Neurology|January 21, 2017
Neuro-oncology in 2016: Advances in brain tumour classification and therapyMatthias Preusser, Christine Marosi
Nature Cancer|March 1, 2024
Improving long-term outcomes in pediatric low-grade gliomaJohannes Gojo, Matthias Preusser
Chinese Clinical Oncology|June 27, 2015
The inflammatory microenvironment in brain metastases: potential treatment target?Anna S Berghoff, Matthias Preusser
Memo|April 3, 2018
Anti-angiogenic therapies in brain metastasesAnna S Berghoff, Matthias Preusser
Neuro-Oncology|November 14, 2023
A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responsesDavid R Raleigh, Matthias Preusser
Nature Reviews. Neurology|April 3, 2019
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?Anna S Berghoff, Matthias Preusser
Therapeutic Advances in Neurological Disorders|July 24, 2018
New developments in brain metastasesAnna S Berghoff, Matthias Preusser
Neuro-Oncology|January 2, 2024
Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomasNathalie L Albert, Matthias Preusser
Pageof 53

Showing results (11-20 of 525) with videos related to

Sort By:
Pageof 53
The Lancet. Oncology|November 6, 2012
Primary systemic treatment of breast-cancer brain metastasesRupert Bartsch, Matthias Preusser
Current Treatment Options in Neurology|May 16, 2015
Antiangiogenic treatment of meningiomasMatthias Preusser, Christine Marosi
Nature Reviews. Neurology|January 21, 2017
Neuro-oncology in 2016: Advances in brain tumour classification and therapyMatthias Preusser, Christine Marosi
Nature Cancer|March 1, 2024
Improving long-term outcomes in pediatric low-grade gliomaJohannes Gojo, Matthias Preusser
Chinese Clinical Oncology|June 27, 2015
The inflammatory microenvironment in brain metastases: potential treatment target?Anna S Berghoff, Matthias Preusser
Memo|April 3, 2018
Anti-angiogenic therapies in brain metastasesAnna S Berghoff, Matthias Preusser
Neuro-Oncology|November 14, 2023
A 34-gene expression biomarker predicts meningioma outcomes and radiotherapy responsesDavid R Raleigh, Matthias Preusser
Nature Reviews. Neurology|April 3, 2019
Does neoadjuvant anti-PD1 therapy improve glioblastoma outcome?Anna S Berghoff, Matthias Preusser
Therapeutic Advances in Neurological Disorders|July 24, 2018
New developments in brain metastasesAnna S Berghoff, Matthias Preusser
Neuro-Oncology|January 2, 2024
Measure what is measurable: PET RANO 1.0 criteria for interpretation of amino acid PET of diffuse gliomasNathalie L Albert, Matthias Preusser
Pageof 53